Related Experiment Video
Updated: Jun 27, 2025
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
New Biomarkers for Systemic Necrotizing Vasculitides
Russka Shumnalieva1,2, Plamena Ermencheva1, Georgi Kotov1
1Department of Rheumatology, Clinic of Rheumatology, University Hospital St. Ivan Rilski, Medical University of Sofia, 13 Urvich St., 1612 Sofia, Bulgaria.
Identifying novel biomarkers for systemic necrotising vasculitides (SNVs) can improve diagnosis, prognosis, and monitoring. These advancements promise enhanced precision medicine and better patient outcomes in SNV management.
Area of Science:
- Rheumatology and Immunology
- Internal Medicine
Background:
- Systemic necrotising vasculitides (SNVs) present complex clinical challenges with variable patient outcomes.
- Current diagnostic and prognostic tools for SNVs require enhancement for personalized medicine.
Purpose of the Study:
- To review emerging biomarkers for improving diagnostic accuracy, prognostic assessment, and disease monitoring in SNVs.
- To explore the potential of novel biomarkers in facilitating earlier detection and personalized treatment strategies for SNVs.
Main Methods:
- Comprehensive literature review of recent advances in immunological biomarkers and inflammatory indicators.
- Analysis of emerging parameters with potential diagnostic and prognostic utility in SNVs.
Main Results:
- Immunological biomarkers and inflammatory indicators show promise for enhanced diagnostic and prognostic capabilities.
- Novel biomarkers are emerging for dynamic disease monitoring, reflecting activity and treatment response.
Conclusions:
- Integrating novel biomarkers into clinical practice can significantly improve the management of SNVs.
- These biomarkers offer potential for earlier detection, more accurate prognostication, and tailored treatment, ultimately improving patient quality of life.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...